2,2-DIFLUOROBENZO[D][1,3]DIOXOL-4-OL, 95.0%, 250mg

1-(BROMOMETHYL)-2-FLUORO-4-NITROBENZENE, 95.0%, 10g

N-(2,4-Difluorophenyl)-4,4-dimethyl-3-oxopentanamide, 95.0%, 5g

1-Amino-2-phenylbutan-2-ol, 97%, 250mg

2-(3-Chloro-phenoxy)-thiazole-4-carboxylic acid ethyl ester, 95.0%, 500mg

4-Nitrobenzylalkohol, min. 99 %, zur Synthese, 100 g, Glasverpackung

Polysucrose 400, 25 g

4-(2-Fluoro-phenyl)-thiazol-2-ylamine, 95.0%, 1g

Methyl 2-(4-ethynylphenyl)acetate, 97%, 1g

1-[(3aS,8aS)-tetrahydro-2,2-diMethyl-4,4,8,8-tetraphenyl-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl]- Piperidine, 98%, 100mg

tert-Butyl-N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-carbamate, 97.0%, 1g

ETHYL 4-AMINO-3-TRIFLUOROMETHOXYBENZOATE, 95.0%, 1g

In Pulverform +2 % MgO 99,999 % 200 Mikron 50 g